GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
WGS is expected to report earnings to fall 19.88% to 6 cents per share on April 30
Q1'25
Est.
$0.06
Q4'24
Beat
by $0.56
Q2'23
Missed
by $0.33
Q1'23
Missed
by $0.90
Q4'22
Missed
by $0.72
The last earnings report on February 18 showed earnings per share of 7 cents, beating the estimate of -47 cents. With 760.73K shares outstanding, the current market capitalization sits at 237.87M.